Danish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Hormone Estradiol Replacement Therapy Additional Herbals

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
Linket gemmes på udklipsholderen
StatusAfsluttet
Sponsorer
Triệu, Nguyễn Thị, M.D.

Nøgleord

Abstrakt

The purpose of this study is to determine whether safety Study of Hormone replacement therapy (HRT) with herbals( Garlic oil+Nattokinase) for estrogen deficiency symptoms in perimenopausal and postmenopausal women.

Beskrivelse

Recent studies have proved :

-Garlic oil as garlic may reduce platelet aggregation, patients taking anticoagulant medication are cautioned about consuming garlic.

A 2013 meta-analysis concluded that garlic preparations may effectively lower total cholesterol by 11-23 mg/dL and LDL cholesterol by 3-15 mg/dL in adults with high cholesterol if taken for longer than two months. The same analysis found that garlic had a marginally positive effect on HDL cholesterol, no significant effect on blood triglyceride levels, and that garlic preparations were generally well tolerated with very few side effects.

- Nattokinase Nattō is made from fermented soybeans and has been eaten in Japan for about a thousand years. Nattō is produced by fermentation by adding the bacterium Bacillus natto to boiled soybeans. Nattokinase is produced by the bacterium acting on the soybeans . While other soy foods contain enzymes, it is only the nattō preparation that contains the specific nattokinase enzyme.

- Estradiol valerate is one of the most widely used esters of estradiol.

- Progesterone: Hormone replacement therapy. Progesterone is combined with 17-beta estradiol in the estrogen patch.

Datoer

Sidst bekræftet: 08/31/2018
Først indsendt: 11/13/2015
Anslået tilmelding indsendt: 11/25/2015
Først indsendt: 11/30/2015
Sidste opdatering indsendt: 09/11/2018
Sidste opdatering indsendt: 09/13/2018
Faktisk startdato for undersøgelsen: 12/31/2008
Anslået primær afslutningsdato: 05/31/2015
Anslået afslutningsdato for undersøgelsen: 05/31/2015

Tilstand eller sygdom

Menopause

Intervention / behandling

Drug: ESTROGEN HERBALS 21

Drug: ESTROGEN HERBALS 28

Fase

Fase 4

Armgrupper

ArmIntervention / behandling
Experimental: ESTROGEN HERBALS 21
Used for women who wish to monthly menstruation Applies to the following strengths: 17β-estradiol 1.5mg/24 hours x 21 days, stop drinking for 7 days. Progesterone 5mg/24 hours x 10 days, stop drinking for 7 days. Garlic oil 30mg/24 hours x 28 days. Enzyme nattokinase 300 FU x 24 hours x 28 days.
Drug: ESTROGEN HERBALS 21
Applies to the following strengths: 17β-estradiol 1.5mg/24 hours x 21 days, stop drinking for 7 days. Progesterone 5 mg/24 hours x 10 days, stop drinking for 7 days. Garlic oil 30mg/24 hours x 28 days. Enzyme nattokinase 300 FU x 24 hours x 28 days.
Experimental: ESTROGEN HERBALS 28
Used for women who do not wish to monthly menstruation Applies to the following strengths: 17β-estradiol 1.5mg/24 hours x 28 days. Garlic oil 30mg/24 hours x 28 days. Enzyme nattokinase 300 FU x 24 hours x 28 days.
Drug: ESTROGEN HERBALS 28
Applies to the following strengths: 17β-estradiol 1.5mg/24 hours x 28 days. Garlic oil 30mg/24 hours x 28 days. Enzyme nattokinase 300 FU x 24 hours x 28 days.

Kriterier for støtteberettigelse

Alder berettiget til undersøgelse 35 Years Til 35 Years
Køn, der er berettiget til undersøgelseFemale
Accepterer sunde frivilligeJa
Kriterier

Inclusion Criteria:

- Hormone replacement therapy (HRT) for oestrogen deficiency symptoms in perimenopausal and postmenopausal women.

- Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

Exclusion Criteria:

- Known, past or suspected breast cancer;

- Known or suspected oestrogen-dependent malignant tumours (eg endometrial cancer);

- Undiagnosed genital bleeding;

- Untreated endometrial hyperplasia;

- Previous or current venous thromboembolism (deep venous thrombosis,pulmonary embolism)

- Known thrombophilic disorders (eg protein C, protein S, or antithrombin deficiency, see section.

- Active or recent arterial thromboembolic disease (eg angina, myocardial infarction);

- Acute liver disease, or a history of liver disease as long as liver function tests have failed to return to normal;

- Known hypersensitivity to the active substances or to any of the excipients;

Resultat

Primære resultatforanstaltninger

1. Time to Estradiol > 35 pg / ml [1 years]

Patients fulfilling inclusion and exclusion criteria. Measure the time to Estradiol > 35 pg / ml Will be divided into two groups Group (A): Females premenopausal Group (B): Females postmenopausal Females premenopausal: (Reference Range: (35-525 pg/mL) Females postmenopausal: (Reference Range:(0-35 pg/mL)

Sekundære resultatforanstaltninger

1. Time to Estradiol > 35 pg / ml [2 years]

- Measure the time to Estradiol > 70 pg /ml.

Deltag i vores
facebook-side

Den mest komplette database med medicinske urter understøttet af videnskab

  • Arbejder på 55 sprog
  • Urtekurer, der understøttes af videnskab
  • Urtegenkendelse ved billede
  • Interaktivt GPS-kort - tag urter på stedet (kommer snart)
  • Læs videnskabelige publikationer relateret til din søgning
  • Søg medicinske urter efter deres virkninger
  • Organiser dine interesser og hold dig opdateret med nyhedsundersøgelser, kliniske forsøg og patenter

Skriv et symptom eller en sygdom, og læs om urter, der kan hjælpe, skriv en urt og se sygdomme og symptomer, den bruges mod.
* Al information er baseret på offentliggjort videnskabelig forskning

Google Play badgeApp Store badge